These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10024109)

  • 1. Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties.
    Schlag G; Redl H; Davies J; Scannon P
    Ann Surg; 1999 Feb; 229(2):262-71. PubMed ID: 10024109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties.
    Ammons WS; Kohn FR; Kung AH
    J Infect Dis; 1994 Dec; 170(6):1473-82. PubMed ID: 7995987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.
    Lin Y; Leach WJ; Ammons WS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):65-9. PubMed ID: 8787881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal/permeability-increasing protein--lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia.
    Giroir BP; Scannon PJ; Levin M
    Crit Care Med; 2001 Jul; 29(7 Suppl):S130-5. PubMed ID: 11445748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: results of a multicenter phase II clinical trial. rBPI21 Acute Hemorrhagic Trauma Study Group.
    Demetriades D; Smith JS; Jacobson LE; Moncure M; Minei J; Nelson BJ; Scannon PJ
    J Trauma; 1999 Apr; 46(4):667-76; discussion 676-7. PubMed ID: 10217232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.
    Levin M; Quint PA; Goldstein B; Barton P; Bradley JS; Shemie SD; Yeh T; Kim SS; Cafaro DP; Scannon PJ; Giroir BP
    Lancet; 2000 Sep; 356(9234):961-7. PubMed ID: 11041396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI.
    Rogy MA; Moldawer LL; Oldenburg HS; Thompson WA; Montegut WJ; Stackpole SA; Kumar A; Palladino MA; Marra MN; Lowry SF
    Ann Surg; 1994 Jul; 220(1):77-85. PubMed ID: 8024362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection.
    Wiezer MJ; Meijer C; Sietses C; Prins HA; Cuesta MA; Beelen RH; Meijer S; van Leeuwen PA
    Ann Surg; 2000 Aug; 232(2):208-15. PubMed ID: 10903599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock.
    Rogy MA; Oldenburg HS; Calvano SE; Montegut WJ; Stackpole SA; Van Zee KJ; Marra MN; Scott RW; Seilhammer JJ; Moldawer LL
    J Clin Immunol; 1994 Mar; 14(2):120-33. PubMed ID: 8195314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
    Zhang LT; Yao YM; Lu JQ; Yan XJ; Yu Y; Sheng ZY
    Shock; 2008 Feb; 29(2):278-84. PubMed ID: 17693935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
    Wiese A; Brandenburg K; Carroll SF; Rietschel ET; Seydel U
    Biochemistry; 1997 Aug; 36(33):10311-9. PubMed ID: 9254630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
    J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease.
    Srivastava A; Casey H; Johnson N; Levy O; Malley R
    Infect Immun; 2007 Jan; 75(1):342-9. PubMed ID: 17101667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons.
    Welty-Wolf KE; Carraway MS; Miller DL; Ortel TL; Ezban M; Ghio AJ; Idell S; Piantadosi CA
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1988-96. PubMed ID: 11734456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability increasing protein (rBPI21) after liver surgery in rats and humans.
    Wiezer MJ; Langendoen SI; Meijer C; Bauer RJ; White ML; Carroll SF; Meyer S; Thijs LG; van Leeuwen PA
    Shock; 1998 Sep; 10(3):161-6; discussion 167-8. PubMed ID: 9744643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial.
    Otto CM; Jackson CB; Rogell EJ; Prior RB; Ammons WS
    J Vet Intern Med; 2001; 15(4):355-60. PubMed ID: 11467593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis.
    Evans TJ; Carpenter A; Moyes D; Martin R; Cohen J
    J Infect Dis; 1995 Jan; 171(1):153-60. PubMed ID: 7798655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates.
    Wiese A; Brandenburg K; Lindner B; Schromm AB; Carroll SF; Rietschel ET; Seydel U
    Biochemistry; 1997 Aug; 36(33):10301-10. PubMed ID: 9254629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil response to Neisseria meningitidis: inhibition of adhesion molecule expression and phagocytosis by recombinant bactericidal/permeability-increasing protein (rBPI21).
    Heyderman RS; Ison CA; Peakman M; Levin M; Klein NJ
    J Infect Dis; 1999 May; 179(5):1288-92. PubMed ID: 10191239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.